Intra-Articular 0.5 % Lidocaine Injection for Osteoarthritis
CompletedPhase 4NCT02632565
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study, investigators compared the efficacy of intra-articular 0.5% lidocaine and saline injection on pain, stiffness and physical function in patients with osteoarthritis.
Study details
- Official title
- Intra-Articular 0.5 % Lidocaine Injection Under Ultrasound Guidance in Chronic Knee Pain Due To Osteoarthritis
- Conditions
- Interventions
- Sponsor
- H. Evren Eker
- Collaborators
- Baskent University
- Organization
- Baskent University
- Start date
- 2009-12
- Primary completion
- 2015-03
- Sex
- All
- Age range
- from 50 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * knee pain for more than 25 of the past 30 days, morning stiffness or less than 30 minutes, crepitation in the knee * pain for more than 25 of the past 30 days and osteophytes on x-ray examination of the knees indicating knee OA Exclusion Criteria: * the knees with a history of mechanical derangement, fibromyalgia, skin lesions and other risk factors of infection, therapy with anticoagulants and trauma/surgery
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02632565